Marilyn Menegus
Concepts (379)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Enterovirus Infections | 13 | 1981 | 10 |
Why?
| Influenza, Human | 7 | 1985 | 94 |
Why?
| Antigens, Viral | 5 | 1991 | 53 |
Why?
| Influenza B virus | 2 | 2002 | 16 |
Why?
| Enterovirus | 13 | 1982 | 11 |
Why?
| Bacterial Infections | 6 | 1985 | 88 |
Why?
| Cytomegalovirus Infections | 9 | 1983 | 39 |
Why?
| Influenza A virus | 3 | 1985 | 63 |
Why?
| Cytomegalovirus | 9 | 1983 | 42 |
Why?
| Virus Diseases | 7 | 1980 | 50 |
Why?
| Streptococcal Infections | 6 | 1989 | 54 |
Why?
| Streptococcus | 3 | 1990 | 34 |
Why?
| Placenta Diseases | 3 | 1992 | 11 |
Why?
| Humans | 77 | 1977 | 1856 |
Why?
| Infant, Newborn | 24 | 1981 | 389 |
Why?
| Pregnancy Complications, Infectious | 5 | 1977 | 35 |
Why?
| Reagent Kits, Diagnostic | 1 | 2002 | 16 |
Why?
| Rhabdomyolysis | 1 | 2001 | 9 |
Why?
| Disseminated Intravascular Coagulation | 1 | 2001 | 10 |
Why?
| Infant, Premature | 4 | 1987 | 70 |
Why?
| Blood | 4 | 1984 | 67 |
Why?
| Sepsis | 3 | 1985 | 73 |
Why?
| Polymerase Chain Reaction | 4 | 1997 | 279 |
Why?
| Leukoplakia, Hairy | 1 | 1999 | 3 |
Why?
| Herpesvirus 4, Human | 1 | 1999 | 34 |
Why?
| Adenovirus Infections, Human | 4 | 1980 | 5 |
Why?
| Adenoviridae Infections | 4 | 1980 | 9 |
Why?
| Infant | 18 | 1980 | 464 |
Why?
| Acquired Immunodeficiency Syndrome | 2 | 1989 | 85 |
Why?
| Herpesvirus 2, Human | 1 | 1996 | 7 |
Why?
| Child, Preschool | 15 | 1980 | 554 |
Why?
| Enterovirus B, Human | 4 | 1983 | 7 |
Why?
| Herpes Simplex | 4 | 1977 | 31 |
Why?
| Herpesviridae Infections | 2 | 1980 | 25 |
Why?
| Male | 34 | 1980 | 1553 |
Why?
| Viremia | 3 | 1984 | 18 |
Why?
| Female | 37 | 1977 | 1643 |
Why?
| Adult | 25 | 1977 | 1317 |
Why?
| Adolescent | 20 | 1980 | 891 |
Why?
| Coxsackievirus Infections | 3 | 1985 | 8 |
Why?
| Dysentery, Bacillary | 2 | 1985 | 9 |
Why?
| Water Microbiology | 3 | 1987 | 13 |
Why?
| Sensitivity and Specificity | 3 | 1997 | 427 |
Why?
| Fever | 3 | 1983 | 65 |
Why?
| Gonorrhea | 3 | 1985 | 13 |
Why?
| Disease Outbreaks | 7 | 1981 | 61 |
Why?
| Shigella sonnei | 1 | 1991 | 6 |
Why?
| Leukocytes, Mononuclear | 1 | 1992 | 67 |
Why?
| Encephalitis | 1 | 1991 | 29 |
Why?
| Water Loss, Insensible | 1 | 1990 | 3 |
Why?
| Cryptococcosis | 1 | 1990 | 8 |
Why?
| Mycobacterium avium-intracellulare Infection | 1 | 1990 | 7 |
Why?
| Candida | 1 | 1990 | 19 |
Why?
| Bandages | 1 | 1990 | 22 |
Why?
| Urethritis | 2 | 1986 | 9 |
Why?
| Chlamydia Infections | 2 | 1986 | 17 |
Why?
| Candidiasis | 1 | 1990 | 28 |
Why?
| Amikacin | 1 | 1990 | 5 |
Why?
| Prospective Studies | 8 | 1984 | 545 |
Why?
| Streptomycin | 1 | 1990 | 5 |
Why?
| Tobramycin | 1 | 1990 | 7 |
Why?
| Epidermis | 1 | 1990 | 30 |
Why?
| Respiratory System | 2 | 1986 | 30 |
Why?
| Gentamicins | 1 | 1990 | 32 |
Why?
| Trichomonas Vaginitis | 1 | 1989 | 3 |
Why?
| Trichomonas vaginalis | 1 | 1989 | 4 |
Why?
| Catheterization, Peripheral | 1 | 1989 | 21 |
Why?
| Meningitis, Viral | 2 | 1981 | 4 |
Why?
| Mycobacterium avium | 1 | 1989 | 2 |
Why?
| Mycobacterium Infections | 1 | 1989 | 11 |
Why?
| Vagina | 1 | 1989 | 30 |
Why?
| Cell Line | 5 | 1983 | 375 |
Why?
| Chickenpox Vaccine | 2 | 1998 | 6 |
Why?
| Virus Cultivation | 3 | 1983 | 24 |
Why?
| Cross Infection | 4 | 1980 | 46 |
Why?
| Sexually Transmitted Diseases | 1 | 1989 | 18 |
Why?
| Hospitalization | 5 | 1984 | 169 |
Why?
| Immunoenzyme Techniques | 4 | 1985 | 125 |
Why?
| Malassezia | 1 | 1987 | 2 |
Why?
| Meningitis, Aseptic | 2 | 1982 | 4 |
Why?
| Pregnancy | 7 | 1977 | 455 |
Why?
| Equipment Contamination | 1 | 1987 | 15 |
Why?
| Stomatitis, Herpetic | 2 | 1984 | 7 |
Why?
| Antigens, Bacterial | 2 | 1985 | 44 |
Why?
| Fluorescent Antibody Technique | 3 | 1982 | 164 |
Why?
| Adenoviruses, Human | 1 | 1987 | 10 |
Why?
| Thrombolytic Therapy | 3 | 1993 | 42 |
Why?
| Measles-Mumps-Rubella Vaccine | 1 | 2007 | 9 |
Why?
| Eye | 1 | 1987 | 37 |
Why?
| Simplexvirus | 3 | 1977 | 33 |
Why?
| Infant, Extremely Low Birth Weight | 1 | 2007 | 7 |
Why?
| Catheterization, Central Venous | 1 | 1987 | 46 |
Why?
| Hepatitis C Antibodies | 1 | 2006 | 4 |
Why?
| Liver Transplantation | 2 | 2005 | 54 |
Why?
| Child | 13 | 1980 | 749 |
Why?
| Parvovirus B19, Human | 1 | 2006 | 6 |
Why?
| New York | 11 | 1980 | 422 |
Why?
| Chlamydia trachomatis | 1 | 1986 | 10 |
Why?
| Parvoviridae Infections | 1 | 2006 | 12 |
Why?
| Ganciclovir | 1 | 2005 | 18 |
Why?
| Infant, Newborn, Diseases | 2 | 1982 | 33 |
Why?
| Interferon-gamma | 2 | 1997 | 133 |
Why?
| Cytopathogenic Effect, Viral | 4 | 1983 | 19 |
Why?
| Pneumonia | 2 | 1984 | 85 |
Why?
| Anemia | 1 | 2006 | 60 |
Why?
| Encephalitis, Viral | 1 | 2005 | 11 |
Why?
| Nucleic Acid Amplification Techniques | 1 | 2005 | 10 |
Why?
| Viral Envelope Proteins | 1 | 2005 | 26 |
Why?
| Genetic Variation | 1 | 2005 | 91 |
Why?
| T-Lymphocytes | 2 | 1998 | 182 |
Why?
| Streptococcus agalactiae | 3 | 1989 | 12 |
Why?
| Herpesvirus 3, Human | 2 | 1998 | 14 |
Why?
| Herpes Genitalis | 1 | 1984 | 9 |
Why?
| Kidney Transplantation | 1 | 2006 | 66 |
Why?
| Immunization, Passive | 1 | 1984 | 39 |
Why?
| Immunologic Deficiency Syndromes | 1 | 1984 | 30 |
Why?
| Immune Sera | 1 | 1983 | 56 |
Why?
| Rubella | 2 | 1981 | 5 |
Why?
| Antiviral Agents | 1 | 2005 | 91 |
Why?
| Antibodies, Viral | 7 | 1984 | 104 |
Why?
| Temperature | 1 | 1983 | 137 |
Why?
| Toxoplasmosis, Congenital | 1 | 1982 | 3 |
Why?
| Staphylococcal Protein A | 1 | 1982 | 5 |
Why?
| Antibodies | 1 | 1983 | 159 |
Why?
| Antibiotic Prophylaxis | 1 | 2002 | 22 |
Why?
| Orthomyxoviridae | 2 | 1995 | 34 |
Why?
| Drug Resistance, Microbial | 3 | 1987 | 53 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 243 |
Why?
| Neisseria gonorrhoeae | 3 | 1985 | 11 |
Why?
| Macaca mulatta | 1 | 2002 | 71 |
Why?
| Myocardial Infarction | 2 | 1995 | 129 |
Why?
| Seasons | 4 | 1984 | 64 |
Why?
| Immunoglobulin G | 4 | 1982 | 191 |
Why?
| Middle Aged | 13 | 1980 | 1161 |
Why?
| Placenta | 2 | 1988 | 48 |
Why?
| Exotoxins | 1 | 2001 | 9 |
Why?
| Plasminogen Activators | 2 | 1995 | 21 |
Why?
| Retrospective Studies | 5 | 1987 | 653 |
Why?
| Bacteremia | 1 | 2001 | 25 |
Why?
| Shock, Septic | 1 | 2001 | 40 |
Why?
| Tissue Plasminogen Activator | 2 | 1995 | 31 |
Why?
| Serologic Tests | 1 | 2000 | 24 |
Why?
| CD8-Positive T-Lymphocytes | 2 | 1999 | 91 |
Why?
| Culture Media | 2 | 1990 | 116 |
Why?
| Food Microbiology | 2 | 1987 | 6 |
Why?
| Spectinomycin | 2 | 1987 | 5 |
Why?
| Antigens, CD57 | 1 | 1999 | 3 |
Why?
| HIV Seronegativity | 1 | 1999 | 13 |
Why?
| Time Factors | 5 | 1983 | 896 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 1998 | 32 |
Why?
| AIDS-Related Opportunistic Infections | 1 | 1999 | 41 |
Why?
| Diagnosis, Differential | 2 | 1985 | 402 |
Why?
| Gastroenteritis | 4 | 1981 | 20 |
Why?
| Vulvitis | 1 | 1977 | 6 |
Why?
| Animals | 6 | 1981 | 1031 |
Why?
| Cost of Illness | 1 | 1998 | 54 |
Why?
| Fetal Blood | 2 | 1982 | 54 |
Why?
| Echovirus Infections | 3 | 1985 | 5 |
Why?
| Interleukin-4 | 1 | 1998 | 62 |
Why?
| Sarcoidosis | 1 | 1977 | 29 |
Why?
| Respiratory Syncytial Viruses | 3 | 1982 | 33 |
Why?
| Health Care Costs | 1 | 1998 | 73 |
Why?
| Warts | 1 | 1997 | 13 |
Why?
| Leukocyte Count | 2 | 1985 | 94 |
Why?
| Feces | 3 | 1981 | 43 |
Why?
| Cocaine | 1 | 1997 | 33 |
Why?
| Age Factors | 5 | 1980 | 480 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1997 | 53 |
Why?
| Tumor Virus Infections | 1 | 1997 | 31 |
Why?
| Immunocompromised Host | 1 | 1997 | 70 |
Why?
| Skin | 2 | 1987 | 177 |
Why?
| Papillomavirus Infections | 1 | 1997 | 39 |
Why?
| Neutropenia | 1 | 1997 | 42 |
Why?
| Cerebrospinal Fluid | 2 | 1982 | 23 |
Why?
| Risk Factors | 5 | 1989 | 555 |
Why?
| Pregnancy Complications | 1 | 1977 | 98 |
Why?
| Papillomaviridae | 1 | 1997 | 37 |
Why?
| Community-Acquired Infections | 1 | 1995 | 17 |
Why?
| Infectious Disease Transmission, Vertical | 1 | 1995 | 27 |
Why?
| Nursing Homes | 2 | 1992 | 55 |
Why?
| Pharynx | 2 | 1984 | 23 |
Why?
| Coronary Aneurysm | 1 | 1993 | 6 |
Why?
| Atherectomy, Coronary | 1 | 1993 | 7 |
Why?
| Meningitis | 2 | 1982 | 17 |
Why?
| Aneurysm, Dissecting | 1 | 1993 | 19 |
Why?
| DNA, Viral | 2 | 2005 | 98 |
Why?
| Respirovirus Infections | 2 | 1982 | 22 |
Why?
| Pneumonia, Viral | 2 | 1980 | 17 |
Why?
| Aging | 1 | 1999 | 275 |
Why?
| Respiratory Syncytial Virus Infections | 1 | 1995 | 35 |
Why?
| Immunohistochemistry | 1 | 1996 | 355 |
Why?
| Monocytes | 2 | 1984 | 124 |
Why?
| Antibodies, Monoclonal | 2 | 1992 | 241 |
Why?
| HIV Infections | 1 | 1999 | 136 |
Why?
| beta-Lactamases | 1 | 1991 | 8 |
Why?
| Kidney | 2 | 1984 | 223 |
Why?
| Restriction Mapping | 1 | 1991 | 74 |
Why?
| DNA Probes | 1 | 1991 | 61 |
Why?
| Nucleic Acid Hybridization | 1 | 1991 | 94 |
Why?
| Streptococcus pyogenes | 1 | 1992 | 26 |
Why?
| Aged | 9 | 1980 | 988 |
Why?
| Aerobiosis | 1 | 1990 | 14 |
Why?
| Lymphocytes | 1 | 1992 | 142 |
Why?
| Polyurethanes | 1 | 1990 | 5 |
Why?
| Mycoses | 2 | 1987 | 22 |
Why?
| Mycobacterium avium Complex | 1 | 1990 | 5 |
Why?
| Enzyme-Linked Immunosorbent Assay | 2 | 1985 | 224 |
Why?
| Cryptococcus neoformans | 1 | 1990 | 7 |
Why?
| Radiometry | 1 | 1990 | 31 |
Why?
| Permeability | 1 | 1990 | 52 |
Why?
| Anti-Infective Agents | 1 | 1991 | 54 |
Why?
| Fibroblasts | 2 | 1983 | 179 |
Why?
| Bacteria | 1 | 1990 | 42 |
Why?
| Virus Replication | 1 | 1992 | 90 |
Why?
| DNA, Bacterial | 1 | 1990 | 67 |
Why?
| Plasmids | 1 | 1991 | 122 |
Why?
| Intensive Care Units, Neonatal | 2 | 1982 | 33 |
Why?
| Acridine Orange | 1 | 1989 | 8 |
Why?
| Gestational Age | 1 | 1990 | 114 |
Why?
| Microbial Sensitivity Tests | 1 | 1990 | 71 |
Why?
| Staining and Labeling | 1 | 1989 | 101 |
Why?
| Biological Markers | 1 | 1991 | 262 |
Why?
| Serotyping | 1 | 1988 | 26 |
Why?
| Cells, Cultured | 2 | 1984 | 447 |
Why?
| Viruses, Unclassified | 1 | 1987 | 2 |
Why?
| Bivalvia | 1 | 1987 | 2 |
Why?
| Immunoglobulin lambda-Chains | 1 | 1987 | 11 |
Why?
| Conjunctivitis, Viral | 1 | 1987 | 2 |
Why?
| Immunoglobulin kappa-Chains | 1 | 1987 | 14 |
Why?
| Haplorhini | 1 | 1987 | 43 |
Why?
| Rubella virus | 1 | 2007 | 3 |
Why?
| Mumps virus | 1 | 2007 | 7 |
Why?
| Measles virus | 1 | 2007 | 10 |
Why?
| Infection | 1 | 1987 | 57 |
Why?
| Risk | 2 | 1982 | 203 |
Why?
| Case-Control Studies | 2 | 1995 | 283 |
Why?
| Central Nervous System Diseases | 1 | 1987 | 33 |
Why?
| Predictive Value of Tests | 1 | 1989 | 321 |
Why?
| Incidence | 2 | 1995 | 336 |
Why?
| Poliovirus | 1 | 1986 | 8 |
Why?
| Hepacivirus | 1 | 2006 | 15 |
Why?
| Hemagglutination Inhibition Tests | 2 | 1982 | 28 |
Why?
| Macaca fascicularis | 1 | 1986 | 36 |
Why?
| Lung | 2 | 1983 | 232 |
Why?
| Food Contamination | 1 | 1987 | 18 |
Why?
| Hepatitis C | 1 | 2006 | 18 |
Why?
| Liver Cirrhosis | 1 | 2006 | 48 |
Why?
| Multiple Sclerosis | 1 | 1987 | 43 |
Why?
| Salmonella Infections | 1 | 1985 | 5 |
Why?
| Meningitis, Haemophilus | 1 | 1985 | 15 |
Why?
| Hepatitis, Viral, Human | 1 | 2005 | 10 |
Why?
| Cercopithecus aethiops | 1 | 1986 | 67 |
Why?
| Viral Load | 1 | 2006 | 53 |
Why?
| Evaluation Studies as Topic | 2 | 1977 | 178 |
Why?
| Specimen Handling | 1 | 1986 | 52 |
Why?
| Coronary Angiography | 2 | 1993 | 49 |
Why?
| Physical Examination | 1 | 1985 | 71 |
Why?
| Picornaviridae Infections | 2 | 1981 | 9 |
Why?
| Reference Values | 1 | 2007 | 278 |
Why?
| Respiratory Tract Infections | 1 | 1987 | 57 |
Why?
| Whooping Cough | 1 | 1985 | 14 |
Why?
| Dental Hygienists | 1 | 1984 | 6 |
Why?
| Sequence Analysis, DNA | 1 | 2005 | 110 |
Why?
| Staphylococcal Infections | 1 | 1985 | 63 |
Why?
| Biopsy | 1 | 2005 | 207 |
Why?
| Diseases in Twins | 1 | 1984 | 30 |
Why?
| Bone Marrow | 1 | 2006 | 109 |
Why?
| Hematology | 1 | 1984 | 11 |
Why?
| RNA, Viral | 1 | 2006 | 91 |
Why?
| Rectum | 1 | 1984 | 29 |
Why?
| Occupational Diseases | 1 | 1984 | 51 |
Why?
| Granulocytes | 1 | 1984 | 46 |
Why?
| Bacteriological Techniques | 1 | 1983 | 29 |
Why?
| Sex Factors | 1 | 1985 | 284 |
Why?
| United States | 3 | 1987 | 604 |
Why?
| Methods | 1 | 1983 | 133 |
Why?
| Immunosorbent Techniques | 1 | 1982 | 22 |
Why?
| Socioeconomic Factors | 1 | 1984 | 144 |
Why?
| Meningoencephalitis | 1 | 1982 | 5 |
Why?
| Age of Onset | 1 | 2002 | 64 |
Why?
| Rabbits | 1 | 1984 | 252 |
Why?
| Leukocytes | 1 | 1984 | 94 |
Why?
| Embryo, Mammalian | 1 | 1983 | 99 |
Why?
| Respiratory Tract Diseases | 1 | 1982 | 34 |
Why?
| Breast Feeding | 1 | 1984 | 45 |
Why?
| Reoviridae Infections | 1 | 1981 | 2 |
Why?
| Acute Disease | 2 | 1977 | 271 |
Why?
| Paralysis | 1 | 1981 | 37 |
Why?
| Base Sequence | 1 | 2005 | 371 |
Why?
| Postoperative Complications | 1 | 2005 | 305 |
Why?
| Aged, 80 and over | 2 | 1995 | 599 |
Why?
| Molecular Sequence Data | 1 | 2005 | 404 |
Why?
| Antigens, CD56 | 1 | 1999 | 16 |
Why?
| Antigens, CD45 | 1 | 1999 | 30 |
Why?
| HLA-DR Antigens | 1 | 1999 | 37 |
Why?
| Australia | 1 | 1998 | 27 |
Why?
| Japan | 1 | 1998 | 25 |
Why?
| Antigens, CD28 | 1 | 1999 | 25 |
Why?
| Chickenpox | 1 | 1998 | 20 |
Why?
| Absenteeism | 1 | 1998 | 26 |
Why?
| Ribonucleases | 1 | 1998 | 42 |
Why?
| Vaginitis | 1 | 1977 | 3 |
Why?
| T-Lymphocyte Subsets | 1 | 1999 | 70 |
Why?
| Herpes Zoster | 1 | 1998 | 17 |
Why?
| Counterimmunoelectrophoresis | 1 | 1977 | 2 |
Why?
| Precipitins | 1 | 1977 | 2 |
Why?
| Immunoelectrophoresis | 1 | 1977 | 20 |
Why?
| Cocaine-Related Disorders | 1 | 1997 | 22 |
Why?
| Mycoplasma Infections | 1 | 1977 | 4 |
Why?
| Mycoplasma | 1 | 1977 | 8 |
Why?
| Mucous Membrane | 1 | 1977 | 37 |
Why?
| Immunity, Cellular | 1 | 1977 | 85 |
Why?
| Immunosuppression | 1 | 1977 | 47 |
Why?
| Leukemia | 1 | 1998 | 70 |
Why?
| Antibody Formation | 1 | 1977 | 89 |
Why?
| Remission Induction | 1 | 1997 | 64 |
Why?
| Lymphocyte Activation | 1 | 1998 | 137 |
Why?
| Flow Cytometry | 1 | 1998 | 216 |
Why?
| Antibodies, Bacterial | 1 | 1977 | 50 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 1999 | 113 |
Why?
| Life Tables | 1 | 1995 | 33 |
Why?
| Perfusion | 1 | 1995 | 73 |
Why?
| Patient Admission | 1 | 1995 | 72 |
Why?
| Population Surveillance | 1 | 1995 | 70 |
Why?
| Odds Ratio | 1 | 1995 | 157 |
Why?
| Proportional Hazards Models | 1 | 1995 | 123 |
Why?
| Coronary Thrombosis | 1 | 1993 | 9 |
Why?
| Length of Stay | 1 | 1995 | 166 |
Why?
| Pediatrics | 1 | 1998 | 133 |
Why?
| Urokinase-Type Plasminogen Activator | 1 | 1993 | 38 |
Why?
| Neutralization Tests | 2 | 1982 | 37 |
Why?
| Recurrence | 1 | 1995 | 261 |
Why?
| HIV-1 | 1 | 1999 | 93 |
Why?
| Electrocardiography | 1 | 1997 | 132 |
Why?
| Complement Fixation Tests | 2 | 1977 | 19 |
Why?
| Prognosis | 1 | 1995 | 388 |
Why?
| Cohort Studies | 1 | 1995 | 332 |
Why?
| Combined Modality Therapy | 1 | 1993 | 219 |
Why?
| Hospitals, University | 1 | 1991 | 59 |
Why?
| Injections, Intramuscular | 1 | 1991 | 43 |
Why?
| Connecticut | 1 | 1990 | 9 |
Why?
| Foodborne Diseases | 1 | 1990 | 10 |
Why?
| DNA Restriction Enzymes | 1 | 1990 | 44 |
Why?
| Follow-Up Studies | 1 | 1995 | 553 |
Why?
| Survival Analysis | 1 | 1991 | 205 |
Why?
| Culture Techniques | 1 | 1988 | 61 |
Why?
| Massachusetts | 1 | 1987 | 22 |
Why?
| Treatment Outcome | 1 | 1995 | 661 |
Why?
| Exudates and Transudates | 1 | 1985 | 15 |
Why?
| Urethra | 1 | 1985 | 22 |
Why?
| Nasal Mucosa | 1 | 1985 | 22 |
Why?
| Cervix Uteri | 1 | 1985 | 38 |
Why?
| Skin Diseases, Infectious | 1 | 1984 | 9 |
Why?
| Influenza A Virus, H1N1 Subtype | 1 | 1985 | 27 |
Why?
| Vaccination | 1 | 1985 | 92 |
Why?
| Microbiological Techniques | 1 | 1982 | 3 |
Why?
| Rhinovirus | 1 | 1982 | 11 |
Why?
| Personnel, Hospital | 1 | 1982 | 17 |
Why?
| Intubation, Intratracheal | 1 | 1982 | 50 |
Why?
| Hand, Foot and Mouth Disease | 1 | 1981 | 1 |
Why?
| Arenaviridae Infections | 1 | 1981 | 1 |
Why?
| Marburg Virus Disease | 1 | 1981 | 1 |
Why?
| Parvoviridae | 1 | 1981 | 1 |
Why?
| Creutzfeldt-Jakob Syndrome | 1 | 1981 | 2 |
Why?
| Ebolavirus | 1 | 1981 | 2 |
Why?
| Mumps | 1 | 1981 | 5 |
Why?
| Patient Isolation | 1 | 1981 | 3 |
Why?
| Rabies | 1 | 1981 | 4 |
Why?
| Poliomyelitis | 1 | 1981 | 5 |
Why?
| Measles | 1 | 1981 | 13 |
Why?
| Smallpox | 1 | 1981 | 8 |
Why?
| Rotavirus | 1 | 1981 | 13 |
Why?
| Positive-Pressure Respiration | 1 | 1980 | 18 |
Why?
| Hospital Bed Capacity, 500 and over | 1 | 1980 | 17 |
Why?
| Epidemiologic Methods | 1 | 1980 | 46 |
Why?
| Immunization | 1 | 1981 | 85 |
Why?
| Orthomyxoviridae Infections | 1 | 1980 | 29 |
Why?
| Double-Blind Method | 1 | 1977 | 274 |
Why?
| Clinical Trials as Topic | 1 | 1977 | 251 |
Why?
|
|
Menegus's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
